Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated from v3.3.3; no changes to core study content, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:47:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Publications section updated: added Improvements in health-related quality of life in patients with transfusion-dependent beta-thalassemia after exagamglogene autotemcel (Blood Advances, 2025, DOI: 10.1182/bloodadvances.2025016702) and removed the earlier ahead-of-print version of the same study. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-08T01:36:38.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record now includes IPD Plan Description and data sharing criteria, and lists new locations (California, Illinois, New York, Pennsylvania, and Tennessee). It also updates the status with Completed/Actual dates and removes outdated sections such as HHS Vulnerability Disclosure and Active, not recruiting.
    Difference
    1%
    Check dated 2025-12-24T14:59:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Minor editorial updates to the Publications section clarify that PubMed-sourced publications are auto-filled and may not relate to the study, and update the revision label from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:51:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Removed a site-wide note about government funding status. The study details, eligibility criteria, and outcomes listed on the page remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:34:08.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Minor layout and formatting updates observed on the page; core study details such as eligibility criteria, primary outcomes, study status, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:13:42.000Z thumbnail image

Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.